Hiroshi Yasui

9PUBLICATIONS
24CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Mechanistic and Clinical Differences Between Daratumumab and Isatuximab in Multiple Myeloma: Emerging Roles of 1q Gain and Immune Remodeling.

|May 11, 2026
Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in Japan.

|Feb 26, 2026
Determinants of Efficacy and Optimization of Chimeric Antigen Receptor T-Cell Therapy for Treating Multiple Myeloma: Current Status and Future Perspectives.

Hiroshi Yasui, Noriko Doki, Wei Yan

|Jan 09, 2026
Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders.

Hiroshi Yasui, Masashi Idogawa, Tadao Ishida

|Dec 19, 2025
Author Correction: Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma.

Wei Yan, Xue Shi, Yun Zhao

|Apr 11, 2025
c-FOS Confers Stem Cell-like Features to Multiple Myeloma Cells in a Bone Marrow Microenvironment.

Naoki Osada, Jiro Kikuchi, Sae Matsuoka

Pageof 2

Frequent Collaborators

3 joint publications

Yusuke Furukawa

2 joint publications

Naoto Takahashi

2 joint publications

Huihan Wang

2 joint publications

Jiro Kikuchi